93 related articles for article (PubMed ID: 1243210)
1. [Endolumbar administration of hydrocortisone in the complex treatment of patients with generalized breast cancer].
Pankov AK; Mindlin SS; Verkhovtseva AI
Vopr Onkol; 1975; 21(5):99-104. PubMed ID: 1243210
[TBL] [Abstract][Full Text] [Related]
2. [The mechanism of action of hydrocortisone administered by lumbar puncture in breast cancer].
Bordiushkov IuN; Mindlin SS; Verkhovtseva AI
Vopr Onkol; 1973; 19(9):19-23. PubMed ID: 4274750
[No Abstract] [Full Text] [Related]
3. [Glucuronic acid, glucuronyltransferase and estrogens in breast cancer and precancer].
Al'pert AE; Zhandarova LF
Vopr Onkol; 1978; 24(10):66-70. PubMed ID: 213895
[TBL] [Abstract][Full Text] [Related]
4. [Urinary hydroxyproline excretion before and after hypophysectomy in patients with bone metastases from breast cancer].
Ditzel J; Jordal R; Riskoer N
Ugeskr Laeger; 1968 Oct; 130(42):1766-71. PubMed ID: 5724711
[No Abstract] [Full Text] [Related]
5. [Low-dose aminoglutethimide (500 mg/day) and hydrocortisone (30 mg/day) in advanced cancer of breast].
Bonneterre J; Pion JM; Demaille A
Bull Cancer; 1987; 74(3):241-7. PubMed ID: 3304478
[TBL] [Abstract][Full Text] [Related]
6. [Aminoglutethimide therapy in advanced breast cancer].
Kühböck J; Ludwig H; Pötzi P; Zielinski C
Wien Med Wochenschr; 1985 Dec; 135(23-24):608-11. PubMed ID: 4096007
[TBL] [Abstract][Full Text] [Related]
7. [The relationship between the course of mammary gland cancer and age and hormonal features of the body].
Solovko AIu
Vopr Onkol; 1969; 15(5):73-7. PubMed ID: 5391126
[No Abstract] [Full Text] [Related]
8. [Urinary hydroxyproline in advanced breast carcinoma and response to treatment with medroxyprogesterone acetate (MAP) in high doses].
Martoni A; Pedelini G; Colalongo G; Biagi R; Mambelli M; Jafelice G; Rocchetta G; Piana E; Pannuti F
Minerva Med; 1980 Sep; 71(31):2215-9. PubMed ID: 7422143
[TBL] [Abstract][Full Text] [Related]
9. [Criteria for evaluating the efficacy of treatment of breast cancer metastases to the bones].
Lichinitser MR; Vyshinskaia GV; Gritsaĭ AA; Kondrat'eva AP; Luk'ianchenko AB
Med Radiol (Mosk); 1986 Feb; 31(2):28-31. PubMed ID: 3951344
[TBL] [Abstract][Full Text] [Related]
10. [Early results of hormonal treatment of advanced breast cancer with aminoglutethimide].
Pieńkowski T; Zborzil J; Siedlecki P; Flis E; Pałucka A; Pieńkowska F; Rubách M; Piotrowski J
Pol Tyg Lek; 1988 Aug; 43(33):1057-9. PubMed ID: 3072540
[No Abstract] [Full Text] [Related]
11. [FSH and steroid hormone excretion in breast cancer during chemotherapy].
Sokolova VD; Sharoukhova KS; Goncharova MG; Murav'eva NI; Smirnova KD
Vopr Onkol; 1972; 18(10):19-22. PubMed ID: 4197020
[No Abstract] [Full Text] [Related]
12. [Hormonal patterns in breast cancers].
Kiricuta I; Frenkel Z; Munteanu S
Arch Geschwulstforsch; 1974; 44(3):260-6. PubMed ID: 4460955
[TBL] [Abstract][Full Text] [Related]
13. Combined endocrine treatment of postmenopausal patients with advanced breast cancer. A randomized trial of tamoxifen vs. tamoxifen plus aminoglutethimide and hydrocortisone.
Rose C; Kamby C; Mouridsen HT; Bastholt L; Brincker H; Skovgaard-Poulsen H; Andersen AP; Loft H; Dombernowsky P; Andersen KW
Breast Cancer Res Treat; 1986; 7 Suppl():S45-50. PubMed ID: 3527306
[TBL] [Abstract][Full Text] [Related]
14. [Endocrine-surgical treatment of skeletal metastases].
Dagradi A; Petronio R
Clin Ortop; 1972; 23(1):1-25. PubMed ID: 5084890
[No Abstract] [Full Text] [Related]
15. [Hormone treatment in women with breast cancer. I. Effect of diethylstilbestrol dipropionate on the clinical course and on the excretion of estrogen in the urine of women with metastatic breast cancer].
Schejbalová L; Vrtílek V; Kadlecová D
Vnitr Lek; 1968 Mar; 14(3):273-6. PubMed ID: 5638964
[No Abstract] [Full Text] [Related]
16. Hypercalcemia in patients with advanced mammary cancer and osseous metastases. Effect of hormone therapy and schedule of treatment.
Donovan AJ; Bethune JE; Berne TV
Am Surg; 1966 Oct; 32(10):673-80. PubMed ID: 5921429
[No Abstract] [Full Text] [Related]
17. [Steroid balance in breast cancers of varying histological structure].
Samundzhan EM; Gorevaia AN; Kartavova NS; Nekrasov PIa
Vopr Onkol; 1980; 26(9):37-41. PubMed ID: 6252695
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of bone metastases of breast cancer with progestogens].
Ryckewaert A; Lemaire V
Rev Rhum Mal Osteoartic; 1974 Jan; 41(1):29-32. PubMed ID: 4820523
[TBL] [Abstract][Full Text] [Related]
19. [Excretion of pituitary and steroid hormones in breast cancer following pituitary irradiation].
Izmaĭlova GE; Sharoukhova KS; Goncharova MG; Kuz'mina ZV; Murav'eva NI
Vestn Akad Med Nauk SSSR; 1972; 27(10):36-9. PubMed ID: 4641120
[No Abstract] [Full Text] [Related]
20. Preliminary trial of aminoglutethimide in breast cancer.
Griffiths CT; Hall TC; Saba Z; Barlow JJ; Nevinny HB
Cancer; 1973 Jul; 32(1):31-7. PubMed ID: 4716782
[No Abstract] [Full Text] [Related]
[Next] [New Search]
